Cabot (NYSE:CBT) Updates FY 2026 Earnings Guidance

Cabot (NYSE:CBTGet Free Report) issued an update on its FY 2026 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 6.150-6.450 for the period, compared to the consensus earnings per share estimate of 6.320. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. UBS Group lifted their target price on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Truist Financial initiated coverage on Cabot in a research note on Monday, June 8th. They issued a “buy” rating and a $98.00 target price for the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. JPMorgan Chase & Co. boosted their target price on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research report on Wednesday, May 13th. Finally, Wall Street Zen lowered shares of Cabot from a “buy” rating to a “hold” rating in a report on Saturday. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $85.80.

View Our Latest Report on CBT

Cabot Stock Performance

CBT stock opened at $90.00 on Tuesday. The firm has a market cap of $4.65 billion, a P/E ratio of 17.01, a P/E/G ratio of 11.46 and a beta of 0.84. The stock’s 50 day simple moving average is $88.03 and its 200 day simple moving average is $79.56. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. Cabot has a 12-month low of $58.33 and a 12-month high of $94.53.

Cabot (NYSE:CBTGet Free Report) last issued its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities research analysts predict that Cabot will post 6.35 EPS for the current year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio is presently 35.73%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Global Retirement Partners LLC raised its stake in shares of Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 466 shares in the last quarter. Danske Bank A S acquired a new position in Cabot during the 3rd quarter valued at about $38,000. Geneos Wealth Management Inc. increased its stake in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the period. Caitong International Asset Management Co. Ltd raised its position in shares of Cabot by 709.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock worth $41,000 after buying an additional 468 shares in the last quarter. Finally, Advisory Services Network LLC bought a new stake in shares of Cabot during the 3rd quarter worth about $57,000. Institutional investors own 93.18% of the company’s stock.

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Stories

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.